Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The orexin story, sleep and sleep disturbances
Fabio Pizza, Lucie Barateau, Yves Dauvilliers, et al.
Journal of Sleep Research (2022) Vol. 31, Iss. 4
Closed Access | Times Cited: 48

Showing 26-50 of 48 citing articles:

Comparative efficacy and safety of lemborexant 5 mg versus 10 mg for the treatment of insomnia: a systematic review
Ume Habiba, Radeyah Waseem, Taha Gul Shaikh, et al.
Neurological Sciences (2023) Vol. 44, Iss. 5, pp. 1533-1541
Closed Access | Times Cited: 2
Sleep Disorder and its Treatment: From Nature to Laboratory
Mohit Varshney, Supriyo Saha, Prinsa Prinsa, et al.
Majalah Obat Tradisional (2024) Vol. 29, Iss. 1, pp. 14-14
Open Access
The Orexinergic System: Neurobiology and Clinical Implications
Shorouq Motwani, Avinash De Sousa
Annals of Indian Psychiatry (2024) Vol. 8, Iss. 2, pp. 89-92
Open Access
High‐resolution HLA sequencing and hypocretin receptor 2 autoantibodies in narcolepsy type 1 and type 2
Samia Hamdan, Pontus Wasling, A. R. Lind
International Journal of Immunogenetics (2024) Vol. 51, Iss. 5, pp. 310-318
Closed Access
Public health implications of sleep health in Black Americans using the socio-ecological model and a life-course approach: A systematic literature review
Maurice J. Chery, Rhoda Moise
Social Sciences & Humanities Open (2024) Vol. 10, pp. 101017-101017
Open Access
Orexin and Sleep Disturbances in Alpha-Synucleinopathies: a Systematic Review
Kausar Raheel, Qi Rui See, Veronica Munday, et al.
Current Neurology and Neuroscience Reports (2024) Vol. 24, Iss. 9, pp. 389-412
Open Access
Connecting clinicians and patients: The language of narcolepsy
Lucie Barateau, Anne Marie Morse, Simerpal K. Gill, et al.
Sleep Medicine (2024) Vol. 124, pp. 510-521
Closed Access
Orexinergic modulation of chronic jet lag-induced deficits in mouse cognitive flexibility
Julius Duske, Nicole D’souza, Dana Mayer, et al.
Neuropsychopharmacology (2024)
Open Access
Is CSF hypocretin level useful for differentiating narcolepsy type 1 and 2?
Oliviero Bruni
European Journal of Paediatric Neurology (2024)
Closed Access
Mineralocorticoid Receptor and Sleep Quality in Chronic Kidney Disease
Juan de la Puente-Aldea, Oscar Lopez-Llanos, Daniel Horrillo, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 12320-12320
Open Access
Efficacy of orexin antagonists for the management of major depressive disorder: A systematic review of randomized clinical trials
Shakila Meshkat, Angela T.H. Kwan, Gia Han Le, et al.
Journal of Affective Disorders (2024) Vol. 372, pp. 409-419
Open Access
Faim et satiété, contrôle comportemental de la prise alimentaire
Éric Bertin
EMC - Endocrinologie - Nutrition (2024) Vol. 35, Iss. 2, pp. 1-6
Closed Access
Normal sleep in humans
Alon Y. Avidan
Elsevier eBooks (2023), pp. 83-116.e1
Closed Access | Times Cited: 1
Orexin Agonists — Two Steps Forward, One Step Back
Nathaniel S. Marshall, Ronald R. Grunstein
New England Journal of Medicine (2023) Vol. 389, Iss. 4, pp. 373-375
Closed Access | Times Cited: 1
Administration of oxathridine, a first‐in‐class histamine‐3 receptor partial agonist in healthy male volunteers: Central nervous system depression and pseudo‐hallucinations
Francis M. Dijkstra, Rob Zuiker, Jules A. A. C. Heuberger, et al.
British Journal of Clinical Pharmacology (2023) Vol. 90, Iss. 1, pp. 321-335
Closed Access | Times Cited: 1
Single sessions of transcranial direct current stimulation and transcranial random noise stimulation exert no effect on sleepiness in patients with narcolepsy and idiopathic hypersomnia
Michaela Hohenester, Berthold Langguth, Thomas C. Wetter, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 1
Orexinergic modulation of chronic jet lag-induced deficits in mouse cognitive flexibility
Markus Fendt, Julius Duske, Nicole D’souza, et al.
Research Square (Research Square) (2024)
Closed Access
Bibliometric analysis of orexin: A promising neuropeptide
Ning Sun, Rui Wei, Bochao Jia, et al.
Medicine (2024) Vol. 103, Iss. 43, pp. e40213-e40213
Open Access
Les antagonistes doubles des recepteurs de l’orexine : une nouvelle approche pharmacologique du traitement de l’insomnie chronique
Régis Lopez
Médecine du Sommeil (2022) Vol. 19, Iss. 3, pp. 195-199
Open Access | Times Cited: 1
Focus on sleep‐related breathing disorders and COVID‐19
Dieter Riemann
Journal of Sleep Research (2023) Vol. 32, Iss. 1
Open Access
Autonomic Dysfunction in Hypersomnia
Alessandro Silvani, Isabelle Lambert, Anna Heidbreder, et al.
Current Sleep Medicine Reports (2023) Vol. 9, Iss. 2, pp. 115-123
Closed Access
Hypersomnies
Régis Lopez
Encyclopédie médico-chirurgicale. Psychiatrie (2023) Vol. 39, Iss. 1, pp. 1-9
Closed Access
Novel 3-Aminopyrrolidine and Piperidine Macrocyclic Orexin Receptor Agonists for Treating Sleep Disorders
Ram W. Sabnis
ACS Medicinal Chemistry Letters (2022) Vol. 13, Iss. 9, pp. 1390-1391
Open Access
Previous Page - Page 2

Scroll to top